Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advanced Cancer Therapeutics
Advanced Cancer Therapeutics Secures Exclusive License to Anti-Cancer Therapeutic from the University of Louisville’s Brown Cancer Center
June 26th, 2009
Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, announced that it has signed an exclusive license to develop and commercialize small molecule compound inhibitors of choline kinase, an enzyme discovered to be required for the survival of tumors by scientists at the University of Louisville's James Graham Brown Cancer Center (Brown Cancer Center). Brown Cancer Center researchers Drs. Brian Clem, Sucheta Telang, Jason Chesney and John Trent recently found that removal of the gene for choline kinase caused a block in signals required for the survival of tumors. Using computing technologies that Dr....
Source: Health Business Week (2009-06-26)
|
